BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23043291)

  • 21. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
    Paucar R; Martín-Escolano R; Moreno-Viguri E; Azqueta A; Cirauqui N; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    Bioorg Med Chem; 2019 Sep; 27(17):3902-3917. PubMed ID: 31345745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi.
    Silva CF; Batista Dda G; Batista MM; Lionel J; Hammer ER; Brun R; Soeiro Mde N
    Parasitology; 2014 Mar; 141(3):367-73. PubMed ID: 24553079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
    Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
    Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
    Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
    Arantes JM; Francisco AF; de Abreu Vieira PM; Silva M; Araújo MS; de Carvalho AT; Pedrosa ML; Carneiro CM; Tafuri WL; Martins-Filho OA; Elói-Santos SM
    Exp Parasitol; 2011 Aug; 128(4):401-8. PubMed ID: 21620835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 2-arylazoimidazole derivatives as inhibitors of Trypanosoma cruzi proliferation: Synthesis and evaluation of their biological activity.
    Salerno A; Celentano AM; López J; Lara V; Gaozza C; Balcazar DE; Carrillo C; Frank FM; Blanco MM
    Eur J Med Chem; 2017 Jan; 125():327-334. PubMed ID: 27688187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.
    Reviriego F; Olmo F; Navarro P; Marín C; Ramírez-Macías I; García-España E; Albelda MT; Gutiérrez-Sánchez R; Sánchez-Moreno M; Arán VJ
    Parasitology; 2017 Aug; 144(9):1133-1143. PubMed ID: 28367781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi.
    Díaz-Chiguer DL; Márquez-Navarro A; Nogueda-Torres B; de la Luz León-Ávila G; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Ambrosio JR; Nieto-Meneses R; Yépez-Mulia L; Hernández-Luis F
    Acta Trop; 2012 Apr; 122(1):108-12. PubMed ID: 22212465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,4-Bis(alkylamino)benzo[g]phthalazines able to form dinuclear complexes of Cu(II) which as free ligands behave as SOD inhibitors and show efficient in vitro activity against Trypanosoma cruzi.
    Rodríguez-Ciria M; Sanz AM; Yunta MJ; Gómez-Contreras F; Navarro P; Sánchez-Moreno M; Boutaleb-Charki S; Osuna A; Castiñeiras A; Pardo M; Cano C; Campayo L
    Bioorg Med Chem; 2007 Mar; 15(5):2081-91. PubMed ID: 17222558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of artesunate against Trypanosma cruzi.
    Olivera GC; Postan M; González MN
    Exp Parasitol; 2015 Sep; 156():26-31. PubMed ID: 26024969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aryl- or heteroaryl-based hydrazinylphthalazine derivatives as new potential antitrypanosomal agents.
    Romero AH; Rodríguez J; García-Marchan Y; Leañez J; Serrano-Martín X; López SE
    Bioorg Chem; 2017 Jun; 72():51-56. PubMed ID: 28359970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
    Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
    Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice.
    Barr SC; Rose D; Jaynes JM
    J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
    Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
    Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.